Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker QURE
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | David D. Meek Director | QURE uniQure N.V. | Sale | 9,080 | $21.25 | $192.9K Sale | Form 4 ↗ |
| Jul 2, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 7,600 | $45.89 | $348.8K Sale | Form 4 ↗ |
| Jul 2, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 4,282 | $45.43 | $194.5K Sale | Form 4 ↗ |
| Jul 2, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 9,200 | $44.43 | $408.8K Sale | Form 4 ↗ |
| Jun 30, 2026 | Walid Abi-Saab Chief Medical Officer | QURE uniQure N.V. | Sale | 20,000 | $46.40 | $928.0K Sale | Form 4 ↗ |
| Jun 30, 2026 | Walid Abi-Saab Chief Medical Officer | QURE uniQure N.V. | Sale | 10,000 | $46.46 | $464.6K Sale | Form 4 ↗ |
| Jun 30, 2026 | Jack Kaye Director | QURE uniQure N.V. | Sale | 17,060 | $46.43 | $792.1K Sale | Form 4 ↗ |
| Jun 30, 2026 | Jack Kaye Director | QURE uniQure N.V. | Sale | 4,107 | $46.49 | $190.9K Sale | Form 4 ↗ |
| Jun 26, 2026 | Walid Abi-Saab Chief Medical Officer | QURE uniQure N.V. | Sale | 1,434 | $46.86 | $67.2K Sale | Form 4 ↗ |
| Jun 25, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 28,716 | $50.02 | $1.4M Sale | Form 4 ↗ |
| Jun 24, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 6,696 | $50.00 | $334.8K Sale | Form 4 ↗ |
| Jun 18, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 37,015 | $50.00 | $1.9M Sale | Form 4 ↗ |
| Jun 18, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 4,656 | $50.00 | $232.8K Sale | Form 4 ↗ |
| Jun 17, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 11,585 | $48.65 | $563.6K Sale | Form 4 ↗ |
| Jun 17, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 33,334 | $45.01 | $1.5M Sale | Form 4 ↗ |
| Jun 17, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 56,929 | $43.43 | $2.5M Sale | Form 4 ↗ |
| Jun 17, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 32,581 | $45.02 | $1.5M Sale | Form 4 ↗ |
| Jun 17, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 6,023 | $43.70 | $263.2K Sale | Form 4 ↗ |
| Jun 17, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 23,977 | $42.61 | $1.0M Sale | Form 4 ↗ |
| Jun 17, 2026 | Madhavan Balachandran Director | QURE uniQure N.V. | Sale | 1,690 | $42.60 | $72.0K Sale | Form 4 ↗ |
| Jun 17, 2026 | Madhavan Balachandran Director | QURE uniQure N.V. | Sale | 4,700 | $43.66 | $205.2K Sale | Form 4 ↗ |
| Jun 17, 2026 | Madhavan Balachandran Director | QURE uniQure N.V. | Sale | 5,295 | $47.08 | $249.3K Sale | Form 4 ↗ |
| Jun 17, 2026 | Jack Kaye Director | QURE uniQure N.V. | Sale | 5,295 | $42.57 | $225.4K Sale | Form 4 ↗ |
| Jun 15, 2026 | Madhavan Balachandran Director | QURE uniQure N.V. | Sale | 10,000 | $27.85 | $278.5K Sale | Form 4 ↗ |
| Jun 15, 2026 | Jeannette Potts Chief Legal Officer | QURE uniQure N.V. | Sale | 5,237 | $27.67 | $144.9K Sale | Form 4 ↗ |
| Jun 11, 2026 | David D. Meek Director | QURE uniQure N.V. | Sale | 1,993 | $27.06 | $53.9K Sale | Form 4 ↗ |
| Jun 11, 2026 | Robert Gut Director | QURE uniQure N.V. | Sale | 2,726 | $27.06 | $73.8K Sale | Form 4 ↗ |
| Jun 11, 2026 | Kylie O'Keefe Chief Customer & Strat Officer | QURE uniQure N.V. | Sale | 15,936 | $27.06 | $431.2K Sale | Form 4 ↗ |
| Jun 11, 2026 | Jeremy P. Springhorn Director | QURE uniQure N.V. | Sale | 1,993 | $27.06 | $53.9K Sale | Form 4 ↗ |
| Jun 11, 2026 | Leonard E. Post Director | QURE uniQure N.V. | Sale | 1,993 | $27.06 | $53.9K Sale | Form 4 ↗ |
| Jun 11, 2026 | Jack Kaye Director | QURE uniQure N.V. | Sale | 1,993 | $27.06 | $53.9K Sale | Form 4 ↗ |
| Jun 11, 2026 | Rachelle Suzanne Jacques Director | QURE uniQure N.V. | Sale | 1,993 | $27.06 | $53.9K Sale | Form 4 ↗ |
| Jun 11, 2026 | Madhavan Balachandran Director | QURE uniQure N.V. | Sale | 1,993 | $27.06 | $53.9K Sale | Form 4 ↗ |
| Jun 10, 2026 | Robert Gut Director | QURE uniQure N.V. | Sale | 1,780 | $26.05 | $46.4K Sale | Form 4 ↗ |
| Jun 10, 2026 | Robert Gut Director | QURE uniQure N.V. | Sale | 3,127 | $26.03 | $81.4K Sale | Form 4 ↗ |
| Jun 10, 2026 | Robert Gut Director | QURE uniQure N.V. | Sale | 2,645 | $26.07 | $69.0K Sale | Form 4 ↗ |
| Jun 3, 2026 | Jack Kaye Director | QURE uniQure N.V. | Sale | 2,645 | $30.01 | $79.4K Sale | Form 4 ↗ |
| May 8, 2026 | Walid Abi-Saab Chief Medical Officer | QURE uniQure N.V. | Sale | 20,000 | $25.00 | $500.0K Sale | Form 4 ↗ |
| May 8, 2026 | Walid Abi-Saab Chief Medical Officer | QURE uniQure N.V. | Sale | 25,000 | $25.10 | $627.5K Sale | Form 4 ↗ |
| Mar 4, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 14,581 | $9.06 | $132.1K Sale | Form 4 ↗ |
| Mar 4, 2026 | Walid Abi-Saab Chief Medical Officer | QURE uniQure N.V. | Sale | 808 | $9.06 | $7,320 Sale | Form 4 ↗ |
| Mar 4, 2026 | Jeannette Potts Chief Legal Officer | QURE uniQure N.V. | Sale | 3,412 | $9.06 | $30.9K Sale | Form 4 ↗ |
| Mar 4, 2026 | Christian Klemt Chief Financial Officer | QURE uniQure N.V. | Sale | 12,000 | $9.06 | $108.7K Sale | Form 4 ↗ |
| Mar 2, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 34,437 | $9.95 | $342.6K Sale | Form 4 ↗ |
| Mar 2, 2026 | Christian Klemt Chief Financial Officer | QURE uniQure N.V. | Sale | 12,532 | $9.95 | $124.7K Sale | Form 4 ↗ |
| Mar 2, 2026 | Jeannette Potts Chief Legal Officer | QURE uniQure N.V. | Sale | 8,578 | $9.95 | $85.4K Sale | Form 4 ↗ |
| Mar 2, 2026 | Walid Abi-Saab Chief Medical Officer | QURE uniQure N.V. | Sale | 1,660 | $9.95 | $16.5K Sale | Form 4 ↗ |
| Feb 25, 2026 | Matthew C. Kapusta CEO, Managing Director, Director | QURE uniQure N.V. | Sale | 12,378 | $23.86 | $295.3K Sale | Form 4 ↗ |
| Feb 25, 2026 | Christian Klemt Chief Financial Officer | QURE uniQure N.V. | Sale | 6,217 | $23.86 | $148.3K Sale | Form 4 ↗ |
| Jan 12, 2026 | Robert Gut Director | QURE uniQure N.V. | Sale | 7,803 | $25.09 | $195.8K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 7:06 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances